Iovance Biotherapeutics, Inc.IOVANASDAQ
Loading
Income Quality Over TimeContracting
Percentile Rank57
3Y CAGR+1.5%
5Y CAGR-0.4%
Year-over-Year Change
Quality of reported income
3Y CAGR
+1.5%/yr
vs -2.5%/yr prior
5Y CAGR
-0.4%/yr
Consistent
Acceleration
+4.0pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.77 | -18.4% |
| 2024 | 0.95 | +16.4% |
| 2023 | 0.81 | +10.2% |
| 2022 | 0.74 | +11.0% |
| 2021 | 0.67 | -15.7% |
| 2020 | 0.79 | -1.7% |
| 2019 | 0.80 | -1.8% |
| 2018 | 0.82 | -4.2% |
| 2017 | 0.85 | +38.4% |
| 2016 | 0.62 | - |